850567-90-7 Usage
Uses
Used in Organic Synthesis:
1,4-DIOXA-SPIRO[4,5]DEC-7-EN-8-BORONIC ACID is used as a reagent in organic synthesis for the formation of carbon-carbon and carbon-heteroatom bonds. Its ability to participate in various bond-forming reactions makes it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 1,4-DIOXA-SPIRO[4,5]DEC-7-EN-8-BORONIC ACID is utilized in the development of new drugs. Its capacity to form stable complexes with biomolecules and enzymes allows for the creation of compounds with potential therapeutic applications.
Used in Agrochemical Development:
Similarly, in agrochemicals, 1,4-DIOXA-SPIRO[4,5]DEC-7-EN-8-BORONIC ACID is employed for the development of new pesticides or other agricultural chemicals. Its interaction with biological targets can lead to the discovery of novel agrochemicals with improved efficacy and selectivity.
Used in Chemical Research:
1,4-DIOXA-SPIRO[4,5]DEC-7-EN-8-BORONIC ACID is also used as a research tool in chemical laboratories. Its unique structure and reactivity make it an important compound for studying reaction mechanisms and exploring new areas of chemical science.
Overall, the diverse applications of 1,4-DIOXA-SPIRO[4,5]DEC-7-EN-8-BORONIC ACID across various industries highlight its significance in modern chemical practice and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 850567-90-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,5,6 and 7 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 850567-90:
(8*8)+(7*5)+(6*0)+(5*5)+(4*6)+(3*7)+(2*9)+(1*0)=187
187 % 10 = 7
So 850567-90-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H13BO4/c10-9(11)7-1-3-8(4-2-7)12-5-6-13-8/h1,10-11H,2-6H2
850567-90-7Relevant academic research and scientific papers
BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS
-
Paragraph 0558; 0561, (2022/03/02)
The present invention is directed to bicyclo[4.1.0]heptane pyrrolidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
Preparation of α-oxygenated ketones by the dioxygenation of alkenyl boronic acids
Patil, Aditi S.,Mo, Dong-Liang,Wang, Heng-Yen,Mueller, Daniel S.,Anderson, Laura L.
supporting information; experimental part, p. 7799 - 7803 (2012/09/08)
Two in two: Dioxygenation of alkenyl boronic acids has been achieved with N-hydroxyphthalimide. The two-step process involves etherification of an alkenyl boronic acid with N-hydroxyphthalimide followed by a [3,3] rearrangement. The dioxygenated product can then be hydrolyzed to form either the corresponding α-hydroxy ketone or the α-benzoyloxy ketone. Copyright
